![]() HilleVax HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. | ||
Founding Date | Founding Date 2011 | Founding Date 2020 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US | Locations Boston, US HQ |
Employees | Employees 1561% increase | Employees 31 |
Valuation ($) | Valuation ($) 487.2 m | Valuation ($) 95.1 m |
Financial | ||
Net income | Net income ($115.2m) (FY, 2025) | Net income ($147.3m) (FY, 2024) |

HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.
View company